Stable Isotope Labelled Burosumab Biosimilar – Anti-FGF23 mAb – Research Grade

Reference: PX-TA1437-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Burosumab Biosimilar - Anti-FGF23 mAb - Research Grade
SourceDrugbank DB14012
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue Ice
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymsKRN-23,UX-023
ReferencePX-TA1437-SIL
Related ProductsPX-P4735
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year
FormulaC6388H9904N1700O2006S46

Description of Burosumab Biosimilar - Anti-FGF23 mAb - Research Grade

General information on Anti-FGF23[Homo sapiens] (Burosumab) Monoclonal Antibody

Burosumab is an human monoclonal IgG1 antibody that targets excess fibroblast growth factor 23 (FGF23) and has been investigated to treat children suffering from X-linked hypophosphatemic rickets.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Burosumab Biosimilar – Anti-FGF23 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products